Image

Conventional and Nano-Metronidazole Irrigation With/Without Activation in Necrotic Teeth With Apical Periodontitis

Conventional and Nano-Metronidazole Irrigation With/Without Activation in Necrotic Teeth With Apical Periodontitis

Recruiting
21-50 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled clinical trial evaluates the effect of conventional metronidazole and nano-formulated metronidazole as root canal irrigants, with and without ultrasonic activation, in patients with necrotic single-rooted teeth associated with apical periodontitis.

A total of 60 participants will be randomly allocated into six equal groups according to the irrigant used and whether ultrasonic activation is performed. Sodium hypochlorite will be used as the conventional control irrigant.

The study will compare the groups regarding post-operative pain and reduction in root canal endotoxin levels. Post-operative pain will be assessed using a Visual Analogue Scale, while endotoxin levels will be measured before and after treatment using an ELISA assay

Description

Effective disinfection of the root canal system is an essential part of successful non-surgical root canal treatment. However, microorganisms and their by-products, including endotoxins, may persist within inaccessible areas of the root canal system and may contribute to post-operative pain and persistent periapical inflammation.

This single-center, randomized, controlled, parallel-group clinical trial is designed to compare conventional metronidazole and nano-formulated metronidazole irrigation with sodium hypochlorite in necrotic single-rooted teeth with apical periodontitis. The study also evaluates the effect of ultrasonic activation on the performance of each irrigant.

Sixty participants will be randomly allocated into six equal groups. The three irrigants evaluated are 2.5% sodium hypochlorite, 0.5% metronidazole, and 0.5% nano-formulated metronidazole. Each irrigant will be evaluated with and without ultrasonic activation using the Ultra X device. Root canal preparation and irrigation procedures will be standardized for all participants.

The primary clinical outcome is post-operative pain, assessed using a 0-to-10 Visual Analogue Scale at 6, 12, 24, 48, and 72 hours after treatment. The biological outcome is the change in root canal endotoxin levels. Samples will be collected before instrumentation and after completion of the irrigation protocol, and endotoxin levels will be quantified using an ELISA assay.

Eligibility

Inclusion Criteria:

  • Patients aged between 21 and 50 years.
  • Patients requiring non-surgical root canal treatment.
  • Single-rooted permanent teeth with necrotic pulp.
  • Teeth diagnosed with apical periodontitis.
  • Teeth with fully formed apices.
  • Patients medically free or with a controlled systemic condition.
  • Patients able to understand the Visual Analogue Scale (VAS).

Exclusion Criteria:

  • Patients with systemic diseases affecting healing, such as uncontrolled diabetes or immunocompromised patients.
  • Patients who received antibiotics or anti-inflammatory drugs within the last 48 hours.
  • Pregnant or lactating women.
  • Previously endodontically treated teeth (retreatment cases).
  • Teeth with root resorption, open apex, root fracture, or severe canal calcification.

Study details
    Pulp Necrosis
    Apical Periodontitis

NCT07897591

October 6 University

31 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.